Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine — Stella

Home/Monkeypox/

View on ClinicalTrials.gov

Recruiting

Back to Monkeypox trials

Trial locations(1 site)

France

CIC 1417Cochin-Pasteur, Paris, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~90 participants

Started

May 2025

Primary completion

November 2026

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.